Substance Misuse in Patients with Schizophrenia
- 作者Dr David J. Kavanagh, John McGrath, John B. Saunders, Glenys Dore, Dianne Clark
- 卷第62卷
- 期第5期
- 文件大小186.96KB
- 发表时间2002-04
- DOI10.2165/00003495-200262050-00003
- 页码743-755
Heparins, Low-Molecular-Weight Heparins, and PentasaccharidesDinwoodey, Danya L.; Ansell, Jack E. · Clinics in Geriatric Medicine · 2006
Heparins and low-molecular-weight heparins: State of the artHarenberg, J. · Pharmacological Research · 1995
An approach to a molecular weight calibration for low molecular weight heparinsE.A. Johnson · 1987
Differentiating Low-Molecular-Weight Heparins Based on Chemical, Biological, and Pharmacologic Properties: Implications for the Development of Generic Versions of Low-Molecular-Weight HeparinsJeske, Walter; Walenga, Jeanine; Hoppensteadt, Debra; Vandenberg, Curtis; Brubaker, Aleah; Adiguzel, Cafer; Bakhos, Mamdouh; Fareed, Jawed · Seminars in Thrombosis and Hemostasis · 2008
Variability of Heparins and Heterogeneity of Low Molecular Weight HeparinsBianchini, Pietro; Liverani, Lino; Spelta, Franco; Mascellani, Giuseppe; Parma, Bruna · Seminars in Thrombosis and Hemostasis · 2007
Low- and ultra-low-molecular-weight heparinsAjay K Kakkar · 2004
Heparins and Stroke: Is There a Place for Low Molecular Weight Heparins?Fields, William · Seminars in Thrombosis and Hemostasis · 1991
Choice of low molecular weight heparinsC. Cimminiello · 2003